Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01570036
Title Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors George E. Peoples
Indications

breast cancer

Therapies

E75

Sargramostim

Trastuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.